Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bristol-Myers Tops Earnings Estimates on Drug Sales
Bloomberg
Thursday, July 24, 2014 - 8:24am
tags:
Bristol-Myers Squibb, earnings
Will Bristol-Myers Squibb (BMY) Disappoint This Earnings Season?
Yahoo/Zacks.com
Wednesday, July 23, 2014 - 6:34pm
tags:
earnings, Bristol-Myers Squibb
Did Boehringer Ingelheim Withhold Pradaxa Data From Regulators?
WSJ Online
Wednesday, July 23, 2014 - 6:29pm
tags:
Pradaxa, Boehringer Ingelheim
Vertex Is Poised For An Earnings Breakout
Yahoo/Benzinga
Wednesday, July 23, 2014 - 6:27pm
tags:
earnings, Vertex Pharmaceuticals
Boston Scientific Rises on Launch of POLARIS Imaging System
Yahoo/Zacks.com
Wednesday, July 23, 2014 - 6:16pm
tags:
Boston Scientific, Polaris Imaging System, Arthroscopy Devices Market, intravascular imaging
Afrezza Is A Brilliant Technology Without A Compelling Marketing Story
Seeking Alpha
Wednesday, July 23, 2014 - 6:14pm
tags:
Afrezza, diabetes, MannKind, inhaled insulin
Gilead Sciences Beats Earnings Forecasts, Sovaldi Sales Strong, Shares Slump
Barron's
Wednesday, July 23, 2014 - 6:09pm
tags:
Gilead Sciences, earnings, Sovaldi
Is Inovio Undervalued After Positive HPV Therapy Results?
Seeking Alpha
Wednesday, July 23, 2014 - 6:06pm
tags:
Inovio, HPV, VGX-3100, vaccines, cervical cancer
Earnings Preview: Lilly counts on newer drugs to drive revenue
The Fly on the Wall
Wednesday, July 23, 2014 - 4:34pm
tags:
Eli Lilly, earnings
FDA approves Gilead Sciences' Zydelig for 3 forms of blood cancer
Yahoo/AP
Wednesday, July 23, 2014 - 4:33pm
tags:
FDA, Zydelig, Gilead Sciences, chronic lymphocytic leukemia, follicular lymphoma, small lymphocytic lymphoma
Ominous Signs For Valeant In The Allergan Q2 Earnings Call
Seeking Alpha
Wednesday, July 23, 2014 - 4:30pm
tags:
earnings, Valeant Pharmaceuticals, Allergan
Inovio Declares Spin-Laden Victory With DNA Vaccine
TheStreet.com
Wednesday, July 23, 2014 - 11:05am
tags:
Inovio, vaccines, DNA vaccines, cervical cancer
How Teva Pharmaceutical Is Attacking the Generics to Defend Its Turf
TheStreet.com
Wednesday, July 23, 2014 - 11:03am
tags:
Teva Pharmaceutical, generics, Copaxone
Abuse of U.S. generic-drug rules costs consumers billions, report says
Yahoo/Reuters
Wednesday, July 23, 2014 - 10:47am
tags:
generics, FDA
Too Early To Tell For Atara Biotherapeutics IPO
Seeking Alpha
Wednesday, July 23, 2014 - 10:41am
tags:
Atara, IPOs
Biogen Idec (BIIB) Stock Spikes Following Second Quarter Earnings Beat
TheStreet.com
Wednesday, July 23, 2014 - 10:39am
tags:
earnings, Biogen Idec
Gilead Earnings Preview: Non-Sovaldi Sales Bogey Of $2.94B May Be Unrealistic
Seeking Alpha
Wednesday, July 23, 2014 - 9:17am
tags:
earnings, Sovaldi, Gilead Science
Shire plans to spend about $225 million on collaboration over potential Hunter syndrome drug
Yahoo/AP
Wednesday, July 23, 2014 - 9:14am
tags:
Shire, Hunter Syndrome, ArmaGen
Prempro Plaintiffs’ Lawyers Settle $62 Million Fee Fight
Bloomberg
Wednesday, July 23, 2014 - 9:11am
tags:
Prempro, Pfizer, breast cancer, Arkansas
GlaxoSmithKline plc Falls On Drop In Profits And Turnover
Motley Fool
Wednesday, July 23, 2014 - 9:08am
tags:
GSK, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.